pulmonologyadvisor1d
Zepbound Approved for Obstructive Sleep Apnea in Patients With Obesity
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...
FDA approves first ever medication for obstructive sleep apnea — here's what that means
Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...
Why Inspire Medical Systems (INSP) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
gastroenterologyadvisor1d
FDA Approves Zepbound for Sleep Apnea in Patients With Obesity
The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.
optometryadvisor2d
Patients With Severe OSA Have Reduced Microcirculation of Optic Nerve Head
Decreased blood flow of the optic nerve head (MA, MV, and MT measurements) was significantly correlated with increased OSA ...
Optical imaging technique offers more precise diagnosis of sleep apnea
Obstructive sleep apnea (OSA) is a common sleep disorder characterized by intermittent airway blockages during sleep, leading ...
Science Daily4d
Obstructive Sleep Apnea News
This is the first time breathing rhythms during ... Sleep Apnea Contributes to Dementia in Older Adults, Especially Women Oct. 31, 2024 — Sleep apnea, a common yet underdiagnosed sleep disorder ...
pulmonologyadvisor13h
Sleep-Disordered Breathing Severity Is Not Linked to Acute Post-Stroke Outcomes
Sleep-disordered breathing improvements were not associated with functional, cognitive, or neurologic outcomes in the first ...